Julie Parkes

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

Indra Neil Guha, Julie Parkes, Paul Roderick et al. · Hepatology · 2007 · 740 citations · Full text

Medicine, Pathology, Clinical Classification Systems +16

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Homie Razavi, Imam Waked, Christoph Sarrazin et al. · Journal of Viral Hepatitis · 2014 · 484 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

Ankur Srivastava, Ruth Gailer, Sudeep Tanwar et al. · Journal of Hepatology · 2019 · 435 citations · Full text

Medicine, Internal Medicine, Early Detection +14

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease

Julie Parkes, Paul Roderick, Scott Harris et al. · Gut · 2010 · 345 citations

Medicine, Internal Medicine, Pathology +17

Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease

Valério Nobili, Julie Parkes, GianFranco Bottazzo et al. · Gastroenterology · 2008 · 266 citations

Medicine, Pathology, Pediatrics +14